Alcoholic liver disease other diagnostic studies

Alcoholic liver disease Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Alcoholic liver disease from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X Ray
CT
MRI
Echocardiography or Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Alcoholic liver disease other diagnostic studies On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Alcoholic liver disease other diagnostic studies All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Alcoholic liver disease other diagnostic studies
CDC on Alcoholic liver disease other diagnostic studies
Alcoholic liver disease other diagnostic studies in the news
Blogs on Alcoholic liver disease other diagnostic studies
Directions to Hospitals Treating Alcoholic liver disease
Risk calculators and risk factors for Alcoholic liver disease other diagnostic studies

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Other Diagnostic Studies

Liver biopsy

• Fatty liver
  • Macrovesicular fat
• Alcoholic hepatitis
  • Polymorphonuclear infiltration
  • Hepatic necrosis
  • Mallory bodies in hepatocytes
  • Perivenular and perisinusoidal fibrosis
  • Ballooning hepatocytes
  • Steatosis
• Alcoholic cirrhosis
  • Micronodular cirrhosis

2010 AASLD/ACG Alcoholic Liver Disease Guidelines : Biopsy (DO NOT EDIT)

Class I

1. " For patients with a clinical diagnosis of severe alcoholic hepatitis (AH) for whom medical treatment is contemplated, or for those in whom reasonable uncertainty exists regarding the underlying diagnosis, a liver biopsy should be considered. This decision will depend on local expertise and ability in performing a liver biopsy in patients with coagulopathy, the patient’s severity of illness, and the type of therapy under consideration (Level of evidence: C) "